Delta Lloyd’s Celgene Corp CELG Stock Holding History

Delta Lloyd’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$10.7M	Buy	82,476 +4,778	+6%	+$585K	0.3%	100
2017 Q1	$9.67M	Buy	77,698 +4,585	+6%	+$549K	0.29%	103
2016 Q4	$8.46M	Buy	73,113 +15,522	+27%	+$1.73M	0.27%	108
2016 Q3	$6.02M	Buy	57,591 +5,120	+10%	+$554K	0.19%	111
2016 Q2	$5.17M	Hold	52,471	–	–	0.17%	113
2016 Q1	$5.25M	Sell	52,471 -6,060	-10%	-$624K	0.17%	116
2015 Q4	$7.01M	Buy	58,531 +1,344	+2%	+$155K	0.24%	85
2015 Q3	$6.19M	Buy	57,187 +2,130	+4%	+$264K	0.2%	114
2015 Q2	$6.37M	Buy	55,057 +20,557	+60%	+$2.35M	0.2%	110
2015 Q1	$3.98M	Sell	34,500 -1,312	-4%	-$157K	0.12%	119
2014 Q4	$4.01M	Buy	35,812 +1,964	+6%	+$207K	0.12%	121
2014 Q3	$3.21M	Buy	33,848 +2,424	+8%	+$219K	0.03%	132
2014 Q2	$2.7M	Buy	31,424 +2,398	+8%	+$182K	0.08%	139
2014 Q1	$2.03M	Sell	29,026 -696,392	-96%	-$55.1M	0.07%	146
2013 Q4	$61.3M	Buy	725,418 +89,860	+14%	+$7.11M	2.15%	12
2013 Q3	$49M	Sell	635,558 -178,016	-22%	-$12.5M	1.88%	10
2013 Q2	$47.6M	Buy	+813,574	New	+$49M	1.83%	13

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delta Lloyd's CELG Position: Q2 2017 in Review

Delta Lloyd increased its Celgene Corp (CELG) stake by 6.1% in Q2 2017, buying an estimated $585K and bringing the position to 82,476 shares worth $10.7M. The position accounts for 0.3% of the portfolio, ranked #100.

Delta Lloyd first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $61.3M in Q4 2013. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Delta Lloyd held 82,476 shares of Celgene Corp worth $10.7M as of Q2 2017.
Delta Lloyd bought 4,778 Celgene Corp shares in Q2 2017, an estimated $585K.
Celgene Corp made up 0.3% of Delta Lloyd's portfolio in Q2 2017, its #100 holding.
Delta Lloyd first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
Delta Lloyd's Celgene Corp position peaked at $61.3M in Q4 2013.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.